Published in Vet Dermatol on January 17, 2009
What causes alopecia areata? Exp Dermatol (2013) 1.14
Alopecia areata. Nat Rev Dis Prim (2017) 0.75
Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc (1995) 1.99
Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol (1994) 1.78
Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet (2007) 1.55
Hair loss after routine immunizations. JAMA (1997) 1.43
Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol (2004) 1.38
Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev (2005) 1.36
Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol (1998) 1.27
Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol (1984) 1.17
Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14
Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol (1984) 1.13
Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol (2005) 1.13
The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. Exp Dermatol (2008) 1.12
Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol (2003) 1.12
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect Immun (2002) 1.05
Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity (1995) 1.01
[Skin diseases associated with chronic hepatitis C]. Orv Hetil (1998) 1.01
Alopecia areata: an autoimmune disease? Exp Dermatol (1999) 1.01
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria? J Clin Endocrinol Metab (2003) 0.96
Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo. J Investig Dermatol Symp Proc (1999) 0.89
Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test. Mem Inst Oswaldo Cruz (2002) 0.89
Alopecia areata in humans and other mammalian species. J Invest Dermatol (1995) 0.88
Alopecia areata in a rhesus monkey (Macaca mulatta). J Med Primatol (2007) 0.86
The pathogenesis of alopecia areata in rodent models. J Investig Dermatol Symp Proc (2003) 0.86
Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci (2002) 0.86
Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. J Immunol (2003) 0.84
Alopecia areata and presence of cytomegalovirus DNA. JAMA (1995) 0.82
Epidemiological evidence of the association between lichen planus and two immune-related diseases. Alopecia areata and ulcerative colitis. Gruppo Italiano Studi Epidemiologici in Dermatologia. Arch Dermatol (1991) 0.82
Murine cytomegalovirus is not associated with alopecia areata in C3H/HeJ mice. J Invest Dermatol (1998) 0.81
[A retrospective study of 200 cases of lichen]. G Ital Dermatol Venereol (1990) 0.81
Gm and Km allotypes in autoimmune diseases. G Ital Cardiol (1992) 0.80
Prevalence and clinical features of skin diseases in chronic HCV infection. A prospective study in 96 patients. Panminerva Med (2002) 0.78
Alopecia areata susceptibility in rodent models. J Investig Dermatol Symp Proc (2003) 0.78
Role of cytomegalovirus replication in alopecia areata pathogenesis. J Cutan Med Surg (2000) 0.77
Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine. Jpn J Infect Dis (2003) 0.77
A molecular approach to alopecia areata. J Invest Dermatol (1995) 0.77
No evidence of cytomegalovirus DNA in alopecia areata. J Invest Dermatol (1998) 0.77
[Study of lichen planus conducted by the IGESD: results, implications for clinical practice, prospects. Italian Group of Epidemiological Studies in Dermatology (IGESD)]. G Ital Dermatol Venereol (1990) 0.77
These is no relationship between hepatitis C virus and alopecia areata. Eur J Dermatol (2006) 0.77
Alopecia areata in Korea (1982-1994). J Dermatol (1995) 0.77
No correlation between cytomegalovirus and alopecia areata. J Invest Dermatol (1996) 0.76
Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. J Hepatol (1990) 0.76
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res (2004) 3.96
Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics (2006) 3.61
Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med (2005) 3.21
Outcomes of prenatal antidepressant exposure. Am J Psychiatry (2002) 3.07
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med (2002) 2.90
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer (2010) 2.43
Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis (2004) 2.35
Vaccines for the twenty-first century society. Nat Rev Immunol (2011) 2.34
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome. Hum Mutat (2007) 2.20
Potential medication dosing errors in outpatient pediatrics. J Pediatr (2005) 2.19
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J (2006) 2.10
FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res (2005) 1.97
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol (2004) 1.89
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis (2006) 1.83
C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res (2007) 1.82
Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf (2006) 1.73
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol (2005) 1.66
Real-time vaccine safety surveillance for the early detection of adverse events. Med Care (2007) 1.66
Integrating mouse anatomy and pathology ontologies into a phenotyping database: tools for data capture and training. Mamm Genome (2008) 1.62
Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care (2006) 1.60
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics (2003) 1.58
The mouse as a model for understanding chronic diseases of aging: the histopathologic basis of aging in inbred mice. Pathobiol Aging Age Relat Dis (2011) 1.56
Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine (2004) 1.55
Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) (2014) 1.54
Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol (2004) 1.53
Molecular networks for the study of TCM pharmacology. Brief Bioinform (2009) 1.53
Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol (2009) 1.52
Vaccine discovery and translation of new vaccine technology. Lancet (2011) 1.51
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine (2009) 1.50
Baicalein selectively induces apoptosis in activated lymphocytes and ameliorates concanavalin a-induced hepatitis in mice. PLoS One (2013) 1.48
Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol (2012) 1.47
Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics (2005) 1.46
Chemical fingerprinting of Liuwei Dihuang Pill and simultaneous determination of its major bioactive constituents by HPLC coupled with multiple detections of DAD, ELSD and ESI-MS. J Pharm Biomed Anal (2008) 1.45
Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci (2011) 1.41
The human face of simulation: patient-focused simulation training. Acad Med (2006) 1.41
Effectiveness of the pneumococcal conjugate vaccine for pneumonia in children. Pediatr Infect Dis J (2011) 1.39
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf (2009) 1.38
Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene. Obesity (Silver Spring) (2010) 1.38
Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol (2004) 1.38
Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics (2003) 1.36
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35
Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology (2005) 1.35
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res (2004) 1.32
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst (2010) 1.30
Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol (2012) 1.28
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA (2006) 1.26
Epidemiology of Group B Streptococcus in developing countries. Vaccine (2013) 1.24
Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility. Nat Nanotechnol (2010) 1.23
Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med (2005) 1.23
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22
Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf (2012) 1.20
Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis (2013) 1.20
Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J (2002) 1.20
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation (2007) 1.19
Genome-wide association mapping of quantitative traits in outbred mice. G3 (Bethesda) (2012) 1.17
Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med (2006) 1.17
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev (2012) 1.15
Mutations in sterol O-acyltransferase 1 (Soat1) result in hair interior defects in AKR/J mice. J Invest Dermatol (2010) 1.15
A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide. J Immunol (2002) 1.14
Penile and scrotal elephantiasis caused by indolent Chlamydia trachomatis infection. Urology (2003) 1.13
Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int J Cancer (2010) 1.13
Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol (2003) 1.12
The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. Exp Dermatol (2008) 1.12
Retinoid metabolism is altered in human and mouse cicatricial alopecia. J Invest Dermatol (2012) 1.10
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother (2013) 1.10
Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics (2010) 1.09
Host DNA repair proteins in response to Pseudomonas aeruginosa in lung epithelial cells and in mice. Infect Immun (2010) 1.09
A single-nucleotide polymorphism in the Abcc6 gene associates with connective tissue mineralization in mice similar to targeted models for pseudoxanthoma elasticum. J Invest Dermatol (2012) 1.08
Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J (2012) 1.08
Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med (2004) 1.08
Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol (2002) 1.07
Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol (2006) 1.07
Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis. PLoS One (2012) 1.07
The mouse pathology ontology, MPATH; structure and applications. J Biomed Semantics (2013) 1.05
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine (2013) 1.05
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf (2007) 1.04
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine (2009) 1.04
Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J (2005) 1.04
A combined HPLC-PDA and HPLC-MS method for quantitative and qualitative analysis of 10 major constituents in the traditional Chinese medicine Zuo Gui Wan. J Pharm Biomed Anal (2009) 1.03
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health (2013) 1.03
Use of a respiratory clinical score among different providers. Pediatr Pulmonol (2004) 1.03
A new cultivation method for microbial oil production: cell pelletization and lipid accumulation by Mucor circinelloides. Biotechnol Biofuels (2011) 1.02
Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infect Dis (2008) 1.02
Gangrenous cutaneous mucormycosis in a child with a solid organ transplant: a case report and review of the literature. Pediatr Dermatol (2003) 1.02
The clinical characteristics and direct medical cost of influenza in hospitalized children: a five-year retrospective study in Suzhou, China. PLoS One (2012) 1.01
Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care (2014) 1.01
Prediction of 24-hour-average PM(2.5) concentrations using a hidden Markov model with different emission distributions in Northern California. Sci Total Environ (2012) 1.01